1
Clinical Trials associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)A Clinical Study on the Safety and Efficacy of Anti-CD19-CD3E-CAR-T Cells in the Treatment of Relapsed or Refractory Autoimmune Disease
This is an investigator-initiated trial to evaluate the safety and efficacy of anti-CD19-CD3E-CAR-T cells in the relapse or refractory autoimmune diseases.
100 Clinical Results associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
100 Translational Medicine associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
100 Patents (Medical) associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)
100 Deals associated with Anti-CD19-CD3E-CAR-T cells(Shanghai Changzheng Hospital)